New research was presented at TCT 2012—the Transcatheter Cardiovascular Therapeutics annual meeting—from October 22-26 in Miami. The features below highlight just some of the studies that emerged from the conference.
Meeting Highlights
Denervation Treatment Beneficial for Refractory PAH
Dual Antiplatelet Therapy Should Not Be Stopped Withing a Year of PCI
Stenting May Improve Sexual Function in Men
Reducing Cardiovascular Events in Patients with ACS
Managing Atherosclerotic Popliteal Artery Stenosis
Renal Nerve Ablation Achieves Long-Term Blood Pressure Benefits
TAVR Successful in Real-World Setting
PFO Closure Device Superior to Medical Management in Repeat Stroke Prevention
Stent With Mesh Covering Achieves Positive Outcomes
Live Coverage
News Releases for TCT 2012
DAY 1
Registries Demonstrate Positive Long-Term Outcomes with TAVR
Review of TAVR Use Offers Significant Advances, Positive Outcomes
Registries Show Low Complication Rates with New Heart Valves
PCI Associated with Lower Stroke Risk than CABG
Globalization of Innovation a “Must Have” to Improve Healthcare Delivery
New Results from SYNTAX, SPIRIT Trials Presented
Second-Generation DES Safer, More Effective than BMS in STEMI at 1 Year
SYNTAX: DES, CABG Comparable in Left Main Disease
COURAGE, FAME: Revascularization More Effective than OMT
Several Trials Highlight DES Comparisons
Meta-Analyses Show Improved Outcomes with DES vs. BMS
DAY 2
HARVi 1.0 iPad App Explains Fundamentals of Hemodynamics
Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release
DEBATE-SFA Favors Predilatation with Drug-Eluting Balloon Before BMS
Repositionable Valves Found Safe, Effective in Two Trials
Successful Device Innovation Focuses on Clinical Needs, Multidisciplinary Approach
Large Study Finds Comparable 8-Month TVF for PES, SES
PFO Closure Back in the Spotlight
DAY 3
Novel Devices Provide Options for LAA Therapy
ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD
Mesh-Covered Stent Shines in MASTER Trial
Presentations Examine Multiple Facets of Antiplatelet Agents
Maintaining Successful Practice Depends on Changing Old Habits, Embracing CV Services Lines
Paradigm Shift from Ischemia to Vulnerable Plaque Needed to Prevent Sudden Coronary Death
FAME 2: FFR-Guided PCI Coste Effective vs. Medical Therapy
DAY 4
Centrifugal Pump Feasible Treatment for Refractory RV Failure
Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness
Positive Results Seen with Angioplasty for Critical Hand Ischemia
Transradial PCI Reduces Bleeding in High-Risk ACS Patients
Day 5
Paclitaxel-Eluting Balloons, Stents Best Angioplasty in Treatment of Restenosis
Radial PCI Bests Femoral in STEMI Patients
More from TCT 2012
TCTMD Connect professional networking site
TCTMD Gold and Prime Premium Subscriptions
Integrated Course for Surgeons
Board Review Course with Self-Assessment
ABCs of Interventional Cardiology
